See more : KPC Pharmaceuticals, Inc. (600422.SS) Income Statement Analysis – Financial Results
Complete financial analysis of BICO Group AB (publ) (CLLKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BICO Group AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- Proto Corporation (PTOVF) Income Statement Analysis – Financial Results
- Shriram City Union Finance Limited (SHRIRAMCIT.NS) Income Statement Analysis – Financial Results
- Helix BioPharma Corp. (HBP.TO) Income Statement Analysis – Financial Results
- CrossFirst Bankshares, Inc. (CFB) Income Statement Analysis – Financial Results
- Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) Income Statement Analysis – Financial Results
BICO Group AB (publ) (CLLKF)
About BICO Group AB (publ)
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.24B | 1.26B | 176.79M | 105.46M | 45.34M | 13.19M | 0.00 |
| Cost of Revenue | 408.90M | 255.00M | 13.18M | 14.10M | 5.78M | 584.00K | 0.00 |
| Gross Profit | 1.83B | 1.00B | 163.62M | 91.36M | 39.56M | 12.60M | 0.00 |
| Gross Profit Ratio | 81.74% | 79.72% | 92.55% | 86.63% | 87.26% | 95.57% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 719.00M | 433.10M | 85.65M | 45.88M | 16.33M | 6.26M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 719.00M | 433.10M | 85.65M | 45.88M | 16.33M | 6.26M | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.85B | 1.24B | 229.70M | 97.57M | 40.27M | 12.19M | 0.00 |
| Cost & Expenses | 3.26B | 1.50B | 242.88M | 111.67M | 46.05M | 12.77M | 0.00 |
| Interest Income | 6.80M | 100.00K | 95.00K | 72.00K | 727.00K | 304.00K | 0.00 |
| Interest Expense | 98.20M | 59.30M | 7.29M | 112.00K | 25.00K | 144.00K | 0.00 |
| Depreciation & Amortization | 940.60M | 191.80M | 26.49M | 7.09M | 2.63M | 415.00K | 22.82K |
| EBITDA | 322.30M | 31.80M | -39.50M | 5.82M | 3.72M | 696.00K | 0.00 |
| EBITDA Ratio | 14.39% | 2.53% | -22.34% | 5.52% | 8.20% | 5.28% | 0.00% |
| Operating Income | -996.90M | -236.90M | -66.09M | -3.75M | 372.00K | -23.00K | 0.00 |
| Operating Income Ratio | -44.51% | -18.84% | -37.38% | -3.56% | 0.82% | -0.17% | 0.00% |
| Total Other Income/Expenses | 243.80M | 23.50M | -7.19M | 3.81M | 696.00K | 160.00K | 0.00 |
| Income Before Tax | -753.10M | -213.40M | -73.28M | 54.00K | 1.07M | 137.00K | 0.00 |
| Income Before Tax Ratio | -33.63% | -16.97% | -41.45% | 0.05% | 2.36% | 1.04% | 0.00% |
| Income Tax Expense | 82.60M | 15.80M | -11.07M | -527.00K | -116.00K | -18.00K | 0.00 |
| Net Income | -832.90M | -227.60M | -61.89M | 581.00K | 1.18M | 155.00K | 0.00 |
| Net Income Ratio | -37.19% | -18.10% | -35.01% | 0.55% | 2.61% | 1.18% | 0.00% |
| EPS | -12.94 | -3.97 | -1.47 | 0.02 | 0.04 | -0.03 | 0.00 |
| EPS Diluted | -12.45 | -3.71 | -1.47 | 0.02 | 0.04 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 64.35M | 57.27M | 42.24M | 34.91M | 30.87M | 25.71M | 6.90M |
| Weighted Avg Shares Out (Dil) | 66.88M | 61.35M | 42.24M | 35.11M | 30.87M | 26.92M | 6.90M |
BICO Group AB (CLLKF) Q3 2024 Earnings Call Transcript
BICO Group AB (publ) (CLLKF) Q2 2024 Earnings Call Transcript
The 3 Best 3D Bioprinting Stocks to Buy Now
Lab Instrument Industry Update - New Commercial Entrants
BICO Group AB (publ) (CLLKF) Q1 2024 Earnings Call Transcript
3 3D Printing Stocks With the Potential to Make You an Overnight Millionaire
BICO Group AB (publ) (CLLKF) Q4 2023 Earnings Call Transcript
BICO: Too Many Unknowns
BICO Group AB (publ) (CLLKF) Q2 2023 Earnings Call Transcript
BICO Group AB (publ) (CLLKF) Q1 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports